Emendo Biotherapeutics develops next generation gene editing tools for genetic disorders, addressing the current technological gaps for realizing the promise of gene therapy.
We leverage our expertise in protein engineering to bring innovative and disruptive protein tools to resolve the bottleneck of the field.
Company Details
- Employees
- 42
- Founded
- -
- Address
- 400w E 61st St, New York,new York 10065,united States
- In****@****bio.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- emendobio.com
- HQ
- New York, New York
Emendo Biotherapeutics Questions
Emendo Biotherapeutics's website is emendobio.com
Emendo Biotherapeutics's LinkedIn profile is https://www.linkedin.com/company/emendo-biotheraputics
Emendo Biotherapeutics has
42 employees.
View email and phone details for 42
employees at Emendo Biotherapeutics.
Emendo Biotherapeutics's industry is
Biotechnology Research
Emendo Biotherapeutics's top competitors are
Biolojic Design, Ltd.,
Ukko,
Biomx (Nyse: Phge),
Nucleai,
Memed,
Cytoreason,
Immunai,
Anima Biotech,
Evogene,
Protalix Biotherapeutics.
Emendo Biotherapeutics's support email address is Info@emendobio.com
Emendo Biotherapeutics's categories are Biotechnology Research
Emendo Biotherapeutics's founding year is 2015
